» Articles » PMID: 37000316

MicroRNA-22-3p in Human Umbilical Cord Mesenchymal Stem Cell-secreted Exosomes Inhibits Granulosa Cell Apoptosis by Targeting KLF6 and ATF4-ATF3-CHOP Pathway in POF Mice

Overview
Journal Apoptosis
Publisher Springer
Date 2023 Mar 31
PMID 37000316
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Human umbilical cord mesenchymal stem cells (hUCMSCs)-derived exosomes carrying microRNAs (miRNAs) have promising therapeutic potential in various disorders, including premature ovarian failure (POF). Previous evidence has revealed the low plasma level of miR-22-3p in POF patients. Nevertheless, exosomal miR-22-3p specific functions underlying POF progression are unclarified.

Methods: A cisplatin induced POF mouse model and in vitro murine ovarian granulosa cell (mOGC) model were established. Exosomes derived from miR-22-3p-overexpressed hUCMSCs (Exos-miR-22-3p) were isolated. CCK-8 assay and flow cytometry were utilized for measuring mOGC cell viability and apoptosis. RT-qPCR and western blotting were utilized for determining RNA and protein levels. The binding ability between exosomal miR-22-3p and Kruppel-like factor 6 (KLF6) was verified using luciferase reporter assay. Hematoxylin-eosin staining, ELISA, and TUNEL staining were performed for examining the alteration of ovarian function in POF mice.

Results: Exos-miR-22-3p enhanced mOGC viability and attenuated mOGC apoptosis under cisplatin treatment. miR-22-3p targeted KLF6 in mOGCs. Overexpressing KLF6 reversed the above effects of Exos-miR-22-3p. Exos-miR-22-3p ameliorated cisplatin-triggered ovarian injury in POF mice. Exos-miR-22-3p repressed ATF4-ATF3-CHOP pathway in POF mice and cisplatin-treated mOGCs.

Conclusion: Exosomal miR-22-3p from hUCMSCs alleviates OGC apoptosis and improves ovarian function in POF mouse models by targeting KLF6 and ATF4-ATF3-CHOP pathway.

Citing Articles

Therapeutic Efficacy and Promise of Human Umbilical Cord Mesenchymal Stem Cell-Derived Extracellular Vesicles in Aging and Age-Related Disorders.

Zhang A, Li Q, Chen Z Int J Mol Sci. 2025; 26(1.

PMID: 39796081 PMC: 11719504. DOI: 10.3390/ijms26010225.


Mesenchymal stem cell-derived extracellular vesicles therapy for primary ovarian insufficiency: a systematic review and meta-analysis of pre-clinical studies.

Rajai Firouzabadi S, Mohammadi I, Ghafourian K, Mofidi S, Firouzabadi S, Hashemi S J Ovarian Res. 2024; 17(1):200.

PMID: 39402602 PMC: 11472498. DOI: 10.1186/s13048-024-01513-1.


Clusterin-carrying extracellular vesicles derived from human umbilical cord mesenchymal stem cells restore the ovarian function of premature ovarian failure mice through activating the PI3K/AKT pathway.

He J, Ao C, Li M, Deng T, Zheng S, Zhang K Stem Cell Res Ther. 2024; 15(1):300.

PMID: 39272156 PMC: 11401318. DOI: 10.1186/s13287-024-03926-7.


Exosomal YB-1 facilitates ovarian restoration by MALAT1/miR-211-5p/FOXO axis.

Zhang M, Xing J, Zhao S, Lu M, Liu Y, Lin L Cell Biol Toxicol. 2024; 40(1):29.

PMID: 38700571 PMC: 11068691. DOI: 10.1007/s10565-024-09871-8.


The remodeling of ovarian function: targeted delivery strategies for mesenchymal stem cells and their derived extracellular vesicles.

Song Y, Wu J, Liu Y, Xu N, Bai H, Wang L Stem Cell Res Ther. 2024; 15(1):90.

PMID: 38539206 PMC: 10976842. DOI: 10.1186/s13287-024-03704-5.


References
1.
Yang Y, Huang W, Yuan L . Effects of Environment and Lifestyle Factors on Premature Ovarian Failure. Adv Exp Med Biol. 2021; 1300:63-111. DOI: 10.1007/978-981-33-4187-6_4. View

2.
Chen M, He Q, Guo J, Wu Q, Zhang Q, Yau Y . Electro-Acupuncture Regulates Metabolic Disorders of the Liver and Kidney in Premature Ovarian Failure Mice. Front Endocrinol (Lausanne). 2022; 13:882214. PMC: 9359440. DOI: 10.3389/fendo.2022.882214. View

3.
Jankowska K . Premature ovarian failure. Prz Menopauzalny. 2017; 16(2):51-56. PMC: 5509972. DOI: 10.5114/pm.2017.68592. View

4.
Sullivan S, Sarrel P, Nelson L . Hormone replacement therapy in young women with primary ovarian insufficiency and early menopause. Fertil Steril. 2016; 106(7):1588-1599. PMC: 5137796. DOI: 10.1016/j.fertnstert.2016.09.046. View

5.
Shareghi-Oskoue O, Aghebati-Maleki L, Yousefi M . Transplantation of human umbilical cord mesenchymal stem cells to treat premature ovarian failure. Stem Cell Res Ther. 2021; 12(1):454. PMC: 8359553. DOI: 10.1186/s13287-021-02529-w. View